SCHEMBL11258792

SCHEMBL11258792

CCCCCC(C=C[C@H]1CCC(=O)[C@@H]1C(OC)OC)OC1CCCCO1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.34
▸ GALR3 O60755 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11258802 1.00 MEN1 (0.34) MEN1GALR3KMT2A
SCHEMBL11258798 1.00 MEN1 (0.34) MEN1GALR3KMT2A
SCHEMBL11246637 0.83 MEN1 (0.45) MEN1GALR3KMT2A
SCHEMBL11246612 0.83 MEN1 (0.45) MEN1GALR3KMT2A
SCHEMBL11246623 0.83 MEN1 (0.45) MEN1GALR3KMT2A
SCHEMBL11482334 0.83 — —
SCHEMBL11250676 0.83 PTGER2 (0.40) MEN1GALR3KMT2A
SCHEMBL11250679 0.83 PTGER2 (0.40) MEN1GALR3KMT2A
SCHEMBL11245401 0.81 — —
SCHEMBL11245403 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4315032-A ANTITHROMBOGENIC AGENTS, ANTIULCER AGENTS TEITIN LIMITED (JP) 1982-02-09 — — US disclosed
EP-0019475-A2 Process for preparing adjacently disubstituted ketones, novel prostaglandins E1 and anti-thrombotic compositions containing them TEIJIN LIMITED (JP) 1980-11-26 — — EP disclosed
Send feedback